THE USE OF 5-PHENYL-2-FURAN KETONES AS ANTIEPILEPTIC AGENTS A method of preventing epileptic seizures in a human or lower animal subject susceptible to said seizures, comprising systemically administering to said subject a safe and effective amount of a compound of the formu1a: wherein (a) X is halo or nil, and Y is a substituent selected from the group consisting of unsubstituted or halogen-substituted methyl, halo, nitro, amino, and methoxy; and (b) R is R1C(O)OH, R1C(O)N(R2)2, or R1N(R2)2; where R1 is C1-C3 alkyl which is unsubstituted or substituted with C1-C2 alkyl; and each R2 is, independently, hydrogen or lower alkyl; or both R2 groups are connected to form a saturated 5- or 6-membered heterocycle containing 1 or 2 heteroatoms selected from oxygen and nitrogen and said heterocycle is unsubstituted or substituted with lower alkyl or hydroxy-substituted lower alkyl; or a pharmaceutically-acceptable salt thereof. Preferably X is halo.
USE OF 5-PHENYL-2-FURAN KETONES AS ANTIEPILEPTIC AGENTS